A single fluorophore sensor detects glucose and pH levels simultaneously using ratiometric optical signals.
Ethylene vinyl acetate aqueous dispersion lowers crude oil pour points without flammable solvents, resolving dispersion stability trade-offs.
Antibody binds both VSIG4 protein forms to suppress anti-inflammatory signals and repolarize macrophages.
Monoclonal antibodies targeting NKp46 detect natural killer cells in formalin-fixed paraffin-embedded tissue samples despite epitope masking.
Monoclonal antibody binds MERS-CoV spike protein to enable simplified diagnostics without complex PCR equipment.
Azobenzene linkers enable selective peptide exchange within major histocompatibility complex molecules, avoiding UV-induced protein damage.
A functionalized metal oxide nanotube sensor detects volatile organic biomarkers through electrical conductance changes.
An enzyme-linked immunosorbent assay uses SXP polypeptides to detect antibodies against Strongylus vulgaris in horse samples.
A bait composition with display moieties isolates cancer-specific immune cells from patient samples.
Native viral antigens preserve authentic epitopes to resolve cross-reactivity issues with recombinant proteins in serological testing.
A unique non-B cell-derived IgG epitope enables targeted antibody and CAR-T therapies against epithelial tumors.
Specific ELISA quantifies RKIP and p-RKIP via distinct antibodies, eliminating invasive tissue biopsies.
Dual EpCAM and seprase targeting isolates invasive CTCs with low epithelial marker expression.
Anti-Ly6E immunoconjugates deliver cytotoxic agents to Ly6E-positive tumors, resolving the trade-off between targeting effectiveness and target specificity.
Engineered yeast biosensors detect peptides using GPCR receptors, overcoming slow immunoassay times for rapid point-of-care diagnostics.
Composite nanotube probes overcome weak fluorescence from small extracellular vesicles by amplifying detection signals.
Lectins capture glycosylated enzymes for intrinsic activity measurement, eliminating purification bottlenecks in high-throughput glycoform analysis.
A monoclonal antibody binds specifically to the human methionyl-tRNA synthetase peptide fragment defined by amino acid residues 861 through 900.
Direct Fc receptor binding measurement replaces complex cell-based bioassays, resolving variability from donor immune status and cell culture conditions.
Switching to competitive ELISA lowers the detection limit to 0.85 ng/mL, resolving low sensitivity issues in invasive aspergillosis diagnosis.
Paramagnetic particles conjugated to MHC complexes enable high-throughput enrichment of rare antigen-specific T cells, bypassing complex isolation procedures.
Replacing asparagine with aspartic acid at position 55 prevents deamidation, maintaining binding affinity and immunoinhibitory activity.
Combines phospholipid and free fatty acid omega-3 forms to enhance membrane fluidity and receptor activation.
Sialic acid modulators disrupt Siglec-ligand interactions to overcome PD1/PDL1 resistance in cancers with dysregulated Myc.
An implantable biosensor array replaces invasive finger pricks with continuous insulin monitoring via a degrading gelatin or polylactic acid coating.
Detecting decreased anti-VEGFR antibody levels enables early ovarian cancer diagnosis and predicts treatment response beyond CA125 limitations.
An inhibitor monolayer on the electrode surface prevents protein interference, enabling accurate noninvasive glucose measurement.
Lectins bind specific sugar markers to label colorectal cancer stem cells, resolving low isolation efficiency caused by absent unique surface antigens.
Antibodies bind human ENO1 to block plasminogen activation, reducing inflammation and cancer metastasis.
A fibrinogen measurement method computes plasma concentration using magnetic particle movement signals and waveform-based hematocrit correction.
Engineering variable regions boosts human TIM-3 affinity, resolving weak tumor killing activity in preclinical models.
A linear VEGFR1 antigen polypeptide enables high-purity detection of serum autoantibodies via ELISA.
A smartphone-powered aptamer fluorescence sensor detects brain natriuretic peptide concentrations using direct plug-in power and optical signal processing.
A lateral flow immunoassay kit detects Factor VIII and Von Willebrand factor antigens in plasma samples using gold nanoparticles.
Supercharging reagents in HPLC mobile phases enhance ionization efficiency, lowering the limit of detection to 0.5 ng/ml for improved analytical sensitivity.
A field effect transistor sensor uses a molecularly imprinted polymer film to detect oxytocin through electrical signal changes.
Fluorescent antibody cell sorting detects viral antigens in host cells, resolving the trade-off between productivity and incubation time.
Human antibodies bind HSV glycoprotein D to block viral entry and inhibit replication in immunocompromised patients.
Label-free LSPR detection using a MoS2 transistor eliminates time-consuming washing steps, achieving 250 fg/mL sensitivity in under 10 minutes.
Magnetic particle separation enables high-sensitivity FGF-23 measurement across a wide concentration range.
Applying keratin hydrolysis peptide solution to tea plants increases L-theanine and polyphenol content.
Biomarker panel stratification reduces invasive cystoscopy needs by resolving diagnostic accuracy versus patient invasiveness trade-offs.
Anti-idiotype antibodies target the unique idiotype region of GP5B83, resolving cross-reactivity issues in GPRC5D-associated cancer diagnostics.
Monoclonal antibodies detect relaxin hormone in blood samples, eliminating fetal harm risks from mechanical palpation while ensuring batch consistency.
Semi-arc clamping parts join sample and binding pads to accelerate liquid diffusion, resolving detection time bottlenecks in clothianidin analysis.
Engineered antibodies reduce off-target binding while maintaining high affinity for AMHR-II, resolving safety and efficacy trade-offs.
Polynucleotide-handling proteins control conjugate movement through a nanopore, enabling single-molecule characterization without bulk analysis contamination.
Automated flow cytometry detects forward and side scattered light to generate scattergrams for identifying infected red blood cells.
An integrated electrochemical aptamer sensor detects analyte concentrations via square wave voltammetry in intact tissue cultures.
Lanthanide chelate lipid nanoparticles carry thousands of fluorescent atoms to amplify time-resolved fluorescence signals in bioaffinity assays.